Filtered By:
Condition: Heart Failure
Countries: Germany Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 89 results found since Jan 2013.

More Europeans Died Because of Heat in 2022 Than Any Year in Recorded History
As the Earth continues to warm, the rising temperatures are contributing to a number of health conditions that are in turn driving up mortality. And for the first time, scientists have figured out a more detailed way to estimate how many deaths can be attributed to heat. In a paper published in Nature Medicine, researchers in Spain and France calculated that more than 61,000 deaths in Europe could be blamed on the heat during the summer of 2022, the hottest summer on record for the continent. (At least until the readings from 2023 are analyzed later this year.) [time-brightcove not-tgx=”true”] “We are pro...
Source: TIME: Health - July 10, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized climate change embargoed study healthscienceclimate Source Type: news

Bioimpedance based determination of cardiac index does not show enough trueness for point of care use in patients with systolic heart failure
AbstractCardiac output (CO) is a key parameter in diagnostics and therapy of heart failure (HF). The thermodilution method (TD) as gold standard for CO determination is an invasive procedure with corresponding risks. As an alternative, thoracic bioimpedance (TBI) has gained popularity for CO estimation as it is non-invasive. However, systolic heart failure (HF) itself might worsen its validity. The present study validated TBI against TD.  In patients with and without systolic HF (LVEF ≤ 50% or>  50% and NT-pro-BNP <  125 pg/ml, respectively) right heart catheterization including TD was performed. TBI (Ta...
Source: Journal of Clinical Monitoring and Computing - April 19, 2023 Category: Information Technology Source Type: research

Outcomes of endovascular repair of infrarenal penetrating aortic ulcers
Conclusions: According to this registry data, endovascular repair of PAU is technically feasible with acceptable perioperative outcomes, but further studies investigating mid- and long-term data are needed before invasive treatment of PAU disease in an elderly and comorbid patient population should be recommended.PMID:36880201 | DOI:10.1024/0301-1526/a001060
Source: VASA. Zeitschrift fur Gefasskrankheiten. Journal for Vascular Diseases - March 7, 2023 Category: Surgery Authors: Johannes Hatzl Christian-Alexander Behrendt Thomas Schmitz-Rixen Reinhart Thomas Grundmann Markus Steinbauer Dittmar B öckler Christian Uhl DIGG Investigators Source Type: research

Circulating ketone bodies and cardiovascular outcomes: the MESA study
CONCLUSION: The study found that elevated endogenous KB in a healthy community-based population is associated with a higher rate of CVD and mortality. Ketone bodies could serve as a potential biomarker for cardiovascular risk assessment.PMID:36881667 | DOI:10.1093/eurheartj/ehad087
Source: Atherosclerosis - March 7, 2023 Category: Cardiology Authors: Elad Shemesh Parag Anilkumar Chevli Tareq Islam Charles A German James Otvos Joseph Yeboah Fatima Rodriguez Christopher deFilippi Joao A C Lima Michael Blaha Ambarish Pandey Muthiah Vaduganathan Michael D Shapiro Source Type: research

Outcomes of endovascular repair of infrarenal penetrating aortic ulcers
Conclusions: According to this registry data, endovascular repair of PAU is technically feasible with acceptable perioperative outcomes, but further studies investigating mid- and long-term data are needed before invasive treatment of PAU disease in an elderly and comorbid patient population should be recommended.PMID:36880201 | DOI:10.1024/0301-1526/a001060
Source: Atherosclerosis - March 7, 2023 Category: Cardiology Authors: Johannes Hatzl Christian-Alexander Behrendt Thomas Schmitz-Rixen Reinhart Thomas Grundmann Markus Steinbauer Dittmar B öckler Christian Uhl DIGG Investigators Source Type: research

Prevalence of peripheral arterial disease, abdominal aortic aneurysm, and risk factors in the Hamburg City Health Study: A Cross-Sectional Analysis
CONCLUSION: In this large population-based cohort study of 10,000 subjects from Hamburg, Germany, a strikingly high prevalence of PAD was revealed. Almost 45% suffered from any index disease, while AAA was only diagnosed in 1.3% of males and 0.2% of females. The high prevalence of atherosclerotic disease and associated cardiovascular risk factors underline that it is essential to increase awareness and fuel efforts for secondary prevention.PMID:36634745 | DOI:10.1016/j.ejvs.2023.01.002
Source: PubMed: Eur J Vasc Endovasc ... - January 12, 2023 Category: Surgery Authors: Christian-Alexander Behrendt G ötz Thomalla David Leander Rimmele Elina Larissa Petersen Raphael Twerenbold Eike Sebastian Debus Tilo K ölbel Stefan Blankenberg Christian Schmidt-Lauber Frederik Peters Birgit-Christiane Zyriax Source Type: research

Comparison of telemonitoring combined with intensive patient support with standard care in patients with chronic cardiovascular disease  - a randomized clinical trial
Conclusions and relevanceAmong patients with atrial fibrillation, heart failure, or treatment-resistant hypertension, the NICC approach was not superior over SoC, despite a significant reduction in all-cause mortality, stroke, myocardial infarction and cardiac decompensation.Trial registration ClinicalTrials.gov Identifier: NCT03317951.
Source: European Journal of Medical Research - January 11, 2023 Category: Research Source Type: research

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab. 2023 Jan 3:101418. doi: 10.1016/j.diabet.2022.101418. Online ahead of print.ABSTRACTBACKGROUND: Continued expansion of indications for sodium-glucose cotransporter-2 inhibitors increases importance of evaluating cardiovascular and kidney efficacy and safety of empagliflozin in patients with type 2 diabetes compared to similar therapies.METHODS: The EMPRISE Europe and Asia study is a non-interventional cohort study using data from 2014-2019 in seven European (Denmark, Finland, Germany, Norway, Spain, Sweden, United Kingdom) and four Asian (Israel, Japan, South Korea, Taiwan) countries. Patients with type 2 d...
Source: Diabetes and Metabolism - January 7, 2023 Category: Endocrinology Authors: Avraham Karasik Stefanie Lanzinger Elise Chia-Hui Tan Daisuke Yabe Dae Jung Kim Wayne H-H Sheu Cheli Melzer-Cohen Reinhard W Holl Kyoung Hwa Ha Kamlesh Khunti Francesco Zaccardi Anuradhaa Subramanian Krishnarajah Nirantharakumar Thomas Nystr öm Leo Niska Source Type: research